INCIDENCE OF IMAGING ABNORMALITIES IN PATIENTS WITH NONPALPABLE CARCINOMA OF THE PROSTATE - IF YOU CAN SEE IT, IS IT STAGE T1C

被引：0
|
作者：
WERNERWASIK, M
WHITTINGTON, R
MALKOWICZ, SB
CORN, BW
ARGER, PH
REISINGER, SA
机构：
来源：
RADIOLOGY | 1995年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [1] PATHOLOGICAL CHARACTERISTICS OF NONPALPABLE PROSTATE-CANCER (STAGE T1C)
    CHANEY, TL
    JENNINGS, S
    AUSTENFELD, MS
    GARCIA, FU
    LABORATORY INVESTIGATION, 1994, 70 (01) : A71 - A71
  • [2] Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1c carcinoma of the prostate
    Presti, JC
    Hovey, R
    Carroll, PR
    Shinohara, K
    JOURNAL OF UROLOGY, 1996, 156 (05): : 1685 - 1690
  • [3] Anterior distribution of stage T1c nonpalpable tumors in radical prostatectomy specimens
    Takashima, R
    Egawa, S
    Kuwao, S
    Baba, S
    UROLOGY, 2002, 59 (05) : 692 - 697
  • [4] Is there a role for magnetic resonance imaging (MRI) in the management of T1C carcinoma prostate?
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 207 - 207
  • [5] MANAGEMENT OF STAGE T1C PROSTATE-CANCER
    GIBBONS, RP
    CANCER, 1995, 75 (07) : 1900 - 1902
  • [6] Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy
    Amiya, Yoshiyasu
    Sasaki, Makoto
    Shima, Takayuki
    Tomiyama, Yuusuke
    Suzuki, Noriyuki
    Murakami, Shino
    Nakatsu, Hiroomi
    Shimazaki, Jun
    PROSTATE INTERNATIONAL, 2015, 3 (01) : 27 - 30
  • [7] Role of brachytherapy in patients with stage T1c, T2a adenocarcinoma of the prostate
    Chan, AJ
    Saltzman, B
    JOURNAL OF ENDOUROLOGY, 2000, 14 (04) : 319 - 324
  • [8] Prediction of pathological stage in patients with clinical stage T1c prostate cancer: The new challenge
    Veltri, RW
    Miller, MC
    Mangold, LA
    O'Dowd, GJ
    Epstein, JI
    Partin, AW
    JOURNAL OF UROLOGY, 2002, 168 (01): : 100 - 104
  • [9] Routine use of magnetic resonance Imaging in the management of T1c carcinoma of the prostate:: Is it necessary?
    Manikandan, Ramaswamy
    Qazi, Hasan A. R.
    Philip, Joe
    Mistry, Rahul
    Lamb, Gabby H.
    Woolfenden, Kenneth A.
    Cornford, Philip A.
    Parsons, Keith F.
    JOURNAL OF ENDOUROLOGY, 2007, 21 (10) : 1171 - 1173
  • [10] Clinical value of prostate-specific antigen-detected prostate carcinoma (stage T1c)
    Manseck, A
    Wirth, M
    ONKOLOGIE, 1997, 20 (04): : 306 - 309
12345